Please login to the form below
hematology
This page shows the latest hematology news and features for those working in and with pharma, biotech and healthcare.
Darzalex powers ahead with frontline myeloma approval in Europe
first investigator to administer daratumumab in human trials and Professor, head of the department of hematology at Vejle Hospital, Denmark.
Latest news
-
China’s BeiGene takes PD-1 antibody into pivotal trials
Jane Huang. , M.D., Chief Medical Officer, Hematology, at. BeiGene (pictured).
-
More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
While the US-based ASCO and ASH congresses tend to get the most important haemato-oncology and blood disorder data readouts, the European Hematology Association (EHA) congress now under way in
-
FDA clears Dova drug for liver-related low blood platelets
Hematology and Oncology Products at the FDA.
-
J&J’s Erleada first US drug for non-metastatic prostate cancer
In the trial supporting approval, Erleada had a robust effect on this endpoint,” said Richard Pazdur, director of the FDA’s Office of Hematology and Oncology Products.
-
Takeda bags EU approval for Adcetris in lymphoma
The ECHELON-1 data were reported at the American Society of Hematology (ASH) meeting in December and showed that Adcetris plus chemotherapy was more effective at extending PFS that chemo alone.
More from news
Approximately 6 fully matching, plus 47 partially matching documents found.
Latest Intelligence
-
Attracting doctors to low-demand specialties
A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being dedicated to haematological malignancies
-
Deal Watch November 2016
This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.
-
Deal Watch July 2016
Portfolio of early-stage hematology candidates &option for recombinant pegasparaginase. Licence, option.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Nanobiotix strengthens US leadership team
Most recently, Dr Obrocea was AbbVie Biotherapeutics' project director and oncology clinical lead, overseeing a number of trials in oncology and hematology.
-
TxCell appoints global scientific advisory board
Prof Chiara Bonini (pictured left) is currently head of the experimental hematology unit at the San Raffaele Scientific Institute, a position she has held since 2008.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Highlights in haematologic malignancy from ASH 2018
Earlier this month, Porterhouse Medical attended the 60. th. American Society of Hematology (ASH) Annual Meeting (). The ASH congress is the most comprehensive haematology event of the year, attracting 25, 000
-
Random42 Attending ASH Annual Meeting in San Diego
Now in its 60th year the American Society of Hematology (ASH) annual meeting and exposition is the premier event in malignant and non-malignant hematology. ... The meeting provides an invaluable educational experience and the opportunity to review
-
PRMA Consulting Ltd
Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,
-
Increasing the speed of knowledge sharing in blood cancer to improve patient care
Society of Hematology XXXVI World Congress in Congress ( ISH), which was hosted by the British Society for Haematology at the 56th Annual Scientific Meeting, between 18th-21st April.
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’s health and rare diseases.
More from PMHub
Approximately 2 fully matching, plus 8 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Great salary and benefits
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Project Manager/ Account Manager
-
Salary TBC
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
Subscribe to our email news alerts
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- 2019: CRISPR and therapeutic gene editing comes of age
- Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
- The 10-year Web Challenge
- Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
- Downloadable Pack: Understanding Multiple Sclerosis
- Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Quick links
Infographics
